BRPI0818807A2 - Método para inibir lesão de reperfusão e/ou enfarte em um paciente em necessidade do mesmo, e, uso de um inibidor de glicoproteína vi de plaqueta - Google Patents

Método para inibir lesão de reperfusão e/ou enfarte em um paciente em necessidade do mesmo, e, uso de um inibidor de glicoproteína vi de plaqueta

Info

Publication number
BRPI0818807A2
BRPI0818807A2 BRPI0818807-6A2A BRPI0818807A BRPI0818807A2 BR PI0818807 A2 BRPI0818807 A2 BR PI0818807A2 BR PI0818807 A BRPI0818807 A BR PI0818807A BR PI0818807 A2 BRPI0818807 A2 BR PI0818807A2
Authority
BR
Brazil
Prior art keywords
platter
glycoprotein
inhibitor
same
patient needing
Prior art date
Application number
BRPI0818807-6A2A
Other languages
English (en)
Inventor
Yongge Liu
Narendra N Tandon
Hisao Takizawa
Junichi Kambayashi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of BRPI0818807A2 publication Critical patent/BRPI0818807A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0818807-6A2A 2007-10-31 2008-10-29 Método para inibir lesão de reperfusão e/ou enfarte em um paciente em necessidade do mesmo, e, uso de um inibidor de glicoproteína vi de plaqueta BRPI0818807A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98433407P 2007-10-31 2007-10-31
PCT/US2008/012311 WO2009058326A1 (en) 2007-10-31 2008-10-29 Uses of a glycoprotein vi (gpvi) inhibitor

Publications (1)

Publication Number Publication Date
BRPI0818807A2 true BRPI0818807A2 (pt) 2014-10-29

Family

ID=40591365

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818807-6A2A BRPI0818807A2 (pt) 2007-10-31 2008-10-29 Método para inibir lesão de reperfusão e/ou enfarte em um paciente em necessidade do mesmo, e, uso de um inibidor de glicoproteína vi de plaqueta

Country Status (16)

Country Link
US (1) US20100297116A1 (pt)
EP (1) EP2212416A4 (pt)
JP (1) JP2011502123A (pt)
KR (1) KR20100075585A (pt)
CN (1) CN101874107A (pt)
AR (1) AR069120A1 (pt)
AU (1) AU2008319336A1 (pt)
BR (1) BRPI0818807A2 (pt)
CA (1) CA2703770A1 (pt)
IL (1) IL205453A0 (pt)
MX (1) MX2010004537A (pt)
RU (1) RU2010121878A (pt)
SG (1) SG185307A1 (pt)
TW (1) TW200936606A (pt)
WO (1) WO2009058326A1 (pt)
ZA (1) ZA201002990B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2336188A1 (en) * 2009-12-18 2011-06-22 Sanofi-Aventis Novel antagonist antibodies and their Fab fragments against GPVI and uses thereof
EP2933269A1 (en) 2009-12-18 2015-10-21 Sanofi Novel antagonist antibodies and their fab fragments against gpvi and uses thereof
EP2397495A1 (en) * 2010-06-21 2011-12-21 Sanofi Novel antagonist antibodies and their Fab fragments against GPVI and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7928066B1 (en) * 1999-05-07 2011-04-19 Aventis Pharma Deutschland Gmbh Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use
US20040001826A1 (en) * 1999-06-30 2004-01-01 Millennium Pharmaceuticals, Inc. Glycoprotein VI and uses thereof
AU7097400A (en) * 1999-09-01 2001-03-26 Otsuka Pharmaceutical Co., Ltd. Platelet membrane glycoprotein vi (gpvi) dna and protein sequences, and uses thereof
EP1224942A1 (en) * 2001-01-23 2002-07-24 Bernhard Dr. Nieswandt Use of JAQ1 (monoclonal antibody anti GPVI) as a medicament for the protection against thrombotic diseases
GB0130543D0 (en) * 2001-12-20 2002-02-06 Univ Cambridge Tech Human antibodies and their use
EP1369128A1 (en) * 2002-06-07 2003-12-10 Procorde GmbH Inhibitors of glycoprotein VI and their therapeutic use
WO2005007800A2 (ja) * 2003-07-18 2005-01-27 Mochida Pharm Co Ltd 抗血小板膜糖蛋白質ⅵモノクローナル抗体
US7645592B2 (en) * 2004-04-29 2010-01-12 Otsuka Pharmaceutical Co., Ltd. Glycoprotein VI antibodies and methods of use thereof
WO2005111083A2 (en) * 2004-04-29 2005-11-24 Otsuka Pharmaceutical Co., Ltd. Antibodies specific for glycoprotein vi and methods of producing these antibodies
CA2606450A1 (en) * 2005-04-28 2006-11-09 Mochida Pharmaceutical Co., Ltd. Anti-platelet membrane glycoprotein vi monoclonal antibody

Also Published As

Publication number Publication date
IL205453A0 (en) 2010-12-30
US20100297116A1 (en) 2010-11-25
JP2011502123A (ja) 2011-01-20
CA2703770A1 (en) 2009-05-07
RU2010121878A (ru) 2011-12-10
AU2008319336A1 (en) 2009-05-07
TW200936606A (en) 2009-09-01
CN101874107A (zh) 2010-10-27
EP2212416A1 (en) 2010-08-04
SG185307A1 (en) 2012-11-29
EP2212416A4 (en) 2013-01-09
ZA201002990B (en) 2011-07-27
AR069120A1 (es) 2009-12-30
WO2009058326A1 (en) 2009-05-07
KR20100075585A (ko) 2010-07-02
MX2010004537A (es) 2010-05-20

Similar Documents

Publication Publication Date Title
BRPI0816318A2 (pt) Dispositivo de liberação transdérmica, e, método para preparar o mesmo
BRPI0816349A2 (pt) sistema, sistema para uso em um poço, e método
BRPI0813356A2 (pt) Inibidores de proteína quinase e métodos para uso dos mesmos
BRPI0909002A2 (pt) aparelho para uso em um poço, sistema, e método para uso em um poço
DE602008000042D1 (de) Vorrichtung zum Lagern und Schärfen von Messern
BRPI0920586A2 (pt) dispositivo de separacao para uso na separacao ,caracterizacao e/ou identificacao de micro-organismos.
ATE492363T1 (de) Schneidwerkzeug und schneideinsatz dafür
BRPI0821493A2 (pt) Inserto de corte, e, ferramenta de corte
NL2002105A1 (nl) Improved Navigation Device and Method.
DE602007009863D1 (de) Verfolgbarkeitsprozess und in dem prozess verwendete sicherheitselemente
IL200632A0 (en) First aid system, procedure for its operation, and protable first-aid device for use especially in the system
BR112012013247A2 (pt) conjunto submarino e método para uso em operações submarinas"
BRPI0813828A2 (pt) Compostos antimicrobianos, a síntese dos mesmos e o uso dos mesmos para o tratamento de infecções em mamíferos
BRPI0922414A2 (pt) inserto e ferramenta de corte.
BRPI0807476A2 (pt) Aparelho eletrônico, e, método de detecção de laço para uso em um aparelho eletrônico.
BRPI0913461A2 (pt) sistema e método para atuar seletivamente de uma localização remota múltiplas ferramentas de poço dentro do poço em um poço
BRPI0722092A2 (pt) Proteínas de plantas antifúngicas e métodos para seu uso
EP2197319A4 (en) ADJUSTABLE ARMREST AND METHOD FOR USE
BRPI0813778A2 (pt) Método para torrefação e pasteurização de superfície de produtos alimentícios.
FI20060864A0 (fi) Integroitu systeemi, laite ja niiden käyttö
BRPI0818807A2 (pt) Método para inibir lesão de reperfusão e/ou enfarte em um paciente em necessidade do mesmo, e, uso de um inibidor de glicoproteína vi de plaqueta
BRPI0509255A (pt) dispositivo compresador, método e máquina para uso do mesmo
EP2233258A4 (en) BLADE ELEMENTS AND EDGE WORKING DEVICE FOR THE BLADE ELEMENT
BRPI0819610A2 (pt) Polinucleotídeos e métodos para aperfeiçoamento de plantas
DE502006000768D1 (de) Windschott zum einsatz in flugzeugen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: C07K 16/28 (2006.01), A61K 39/00 (2006.01)

B350 Update of information on the portal [chapter 15.35 patent gazette]